🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SENEA and executed a BUY strategy, securing a +19.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$SVRA

Savara Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP0.45%
MAX GAP RECORD7.18%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY1.9%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL